The surgical treatment of inflammatory bowel disease-associated dysplasia

Expert Review of Gastroenterology and Hepatology

Volumn 7, Issue 4, 2013, Pages 307-322

  Connelly, Tara M ^a   Koltun, Walter A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

colorectal carcinoma; Crohn's disease; dysplasia; inflammatory bowel disease; total proctocolectomy; ulcerative colitis

Indexed keywords

ADENOMA LIKE DYSPLASIA ASSOCIATED LESION; ADENOMA LIKE MASS; CANCER RISK; CHROMOENDOSCOPY; COLORECTAL CARCINOMA; COMORBIDITY; CROHN DISEASE; DISEASE COURSE; DOUBLE STAPLED TECHNIQUE; DYSPLASIA; DYSPLASIA ASSOCIATED LESION OR MASS; END ILEOSTOMY; ENTERITIS; HIGH GRADE DYSPLASIA; HUMAN; ILEOANAL ANASTOMOSIS; ILEOSTOMY; LOW GRADE DYSPLASIA; MUCOSECTOMY; PATIENT PREFERENCE; PRACTICE GUIDELINE; PROCTOCOLECTOMY; REVIEW; SURGICAL TECHNIQUE; TOTAL COLON RESECTION; TREATMENT CONTRAINDICATION; ULCERATIVE COLITIS;

COLECTOMY; COLITIS, ULCERATIVE; COLON; COLONIC POUCHES; COLORECTAL NEOPLASMS; CROHN DISEASE; HUMANS; ILEOSTOMY; PATIENT SELECTION; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84877268962     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.13.17     Document Type: Review

References (58)

1. Goel GA, Kandiel A, Achkar JP, Lashner B. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications. Am. J. Gastroenterol. 106(4), 719-730 (2011).
2. Tang J, Sharif O, Pai C, Silverman AL. Mesalamine protects against colorectal cancer in inflammatory bowel disease. Dig. Dis. Sci. 55(6), 1696-1703 (2010).
3. Goldstone R, Itzkowitz S, Harpaz N, Ullman T. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest. Endosc. 74(5), 1087-1093 (2011).
4. Bergeron V, Vienne A, Sokol H et al. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am. J. Gastroenterol. 105(11), 2405-2411 (2010).
5. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn's disease and colorectal cancer. Gut 35(5), 651-655 (1994).
6. Averboukh F, Ziv Y, Kariv Y et al. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis. Colorectal Dis. 13(11), 1230-1235 (2011).
7. Svrcek M, Cosnes J, Beaugerie L et al. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology 50(5), 574-583 (2007).
8. Rutter MD, Saunders BP, Wilkinson KH et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130(4), 1030-1038 (2006).
9. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig. Dis. Sci. 34(10), 1536-1541 (1989).
10. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4), 526-535 (2001).
11. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31(7), 800-806 (1990).
12. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a populationbased study. Cancer 91(4), 854-862 (2001).
13. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn's disease. Gut 21(12), 1024-1029 (1980).
14. Laukoetter M, Mennigen R, Hannig C et al. Intestinal cancer risk in Crohn's Disease: a meta-analysis. J. Gastrointestinal Surg. 15, 576-583 (2011)
15. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment. Pharmacol. Ther. 23(8), 1097-1104 (2006).
16. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis. Colon Rectum 50(6), 839-855 (2007).
17. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80(2), 366-374 (1981).
18. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from patients. Am. J. Surg. Pathol. 22(3), 275-284 (1998).
19. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117(6), 1288-1294; discussion 1488 (1999).
20. Rubin PH, Friedman S, Harpaz N et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117(6), 1295-1300 (1999).
21. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125(5), 1311-1319 (2003).
22. Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis. Colon Rectum 45(5), 615-620 (2002).
23. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment. Pharmacol. Ther. 25(6), 657-668 (2007).
24. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343(8889), 71-74 (1994).
25. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 120(4), 820-826 (2001).
26. Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum Jr. Intestinal adenocarcinoma in Crohn's disease: a report of cases with a focus on coexisting dysplasia. Am. J. Surg. Pathol. 23(6), 651-655 (1999).
27. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Ann. Surg. 252(2), 330-335 (2010).
28. von Herbay A, Herfarth C, Otto HF. Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z. Gastroenterol. 32(7), 382-388 (1994).
29. Gorfine SR, Bauer JJ, Harris MT, Kreel I. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted? Dis. Colon Rectum 43(11), 1575-1581 (2000).
30. Greenstein AJ, Slater G, Heimann TM, Sachar DB, Aufses AH Jr. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann. Surg. 203(2), 123-128 (1986).
31. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35(7), 950-954 (1994).
32. Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare Study. Dis. Colon Rectum 55(3), 270-277 (2012).
33. Farraye FA, Odze RD, Eaden J et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138(2), 738-745 (2010).
34. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest. Endosc. 51(2), 123-128 (2000).
35. Rutter MD. A practical guide and review of colonoscopic surveillance and chromoendoscopy in patients with colitis. Frontline Gastroenterol. doi:10.1136/ fg.2010.001438.1-5 (2010) (Epub ahead of print).
36. Friedman S, Rubin PH, Bodian C, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning years. Clin. Gastroenterol. Hepatol. 6(9), 993-998; quiz 953 (2008).
37. Basseri RJ, Basseri B, Vassilaki ME et al. Colorectal cancer screening and surveillance in Crohn's colitis. J. Crohns. Colitis 6(8), 824-829 (2012).
38. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107(4), 934-944 (1994).
39. Maykel JA, Hagerman G, Mellgren AF et al. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis. Colon Rectum 49(7), 950-957 (2006).
40. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 52(8), 1127-1132 (2003).
41. Marion JF, Waye JD, Present DH et al.; Chromoendoscopy Study Group at Mount Sinai School of Medicine. Chromoendoscopy- targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am. J. Gastroenterol. 103(9), 2342-2349 (2008).
42. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124(4), 880-888 (2003).
43. Subramanian V, Mannath J, Ragunath K, Hawkey CJ. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment. Pharmacol. Ther. 33(3), 304-312 (2011).
44. Kiesslich R, Neurath MF. Chromoendoscopy in inflammatory bowel disease. Gastroenterol. Clin. North Am. 41(2), 291-302 (2012).
45. Kariv R, Remzi FH, Lian L et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 139(3), 806-812, 812.e1 (2010).
46. Ziv Y, Fazio VW, Strong SA, Oakley JR, Milsom JW, Lavery IC. Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy. Ann. Surg. Oncol. 1(6), 512-515 (1994).
47. M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int. J. Colorectal Dis. 26(5), 533-552 (2011).
48. Chapman JR, Larson DW, Wolff BG et al. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch. Surg. 140(6), 534-539; discussion 539 (2005).
49. Delaney CP, Fazio VW, Remzi FH et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann. Surg. 238(2), 221-228 (2003).
50. Pinto RA, Canedo J, Murad-Regadas S, Regadas SF, Weiss EG, Wexner SD. Ileal pouch-anal anastomosis in elderly patients: is there a difference in morbidity compared with younger patients? Colorectal Dis. 13(2), 177-183 (2011).
51. Taylor BA, Wolff BG, Dozois RR, Kelly KA, Pemberton JH, Beart RW Jr. Ileal pouch-anal anastomosis for chronic ulcerative colitis and familial polyposis coli complicated by adenocarcinoma. Dis. Colon Rectum 31(5), 358-362 (1988).
52. Remzi FH, Preen M. Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Colorectal Dis. 5(5), 483-485 (2003).
53. Gorfine SR, Gelernt IM, Bauer JJ, Harris MT, Kreel I. Restorative proctocolectomy without diverting ileostomy. Dis. Colon Rectum 38(2), 188-194 (1995).
54. Johnson WR, McDermott FT, Hughes ES, Pihl EA, Milne BJ, Price AB. The risk of rectal carcinoma following colectomy in ulcerative colitis. Dis. Colon Rectum 26(1), 44-46 (1983).
55. Kiran RP, Nisar PJ, Goldblum JR et al. Dysplasia associated with Crohn's colitis: segmental colectomy or more extended resection? Ann. Surg. 256(2), 221-226 (2012).
56. Le Q, Melmed G, Dubinsky M et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm. Bowel Dis. 19(1), 30-36 (2013).
57. Freeman HJ. Colorectal cancer complicating Crohn's disease. Can. J. Gastroenterol. 15(4), 231-236 (2001).
58. Koltun WA. Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective. Expert Rev. Gastroenterol. Hepatol. 3(4), 325-327 (2009).